Diligence memo · auto-generated · as of July 2, 2026
Avia Biosystems, Inc.
Avia Biosystems, Inc. looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Avia Biosystems, Inc. operates in Manufacturing, based in NORTON.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Avia Biosystems, Inc. has raised $1.1M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $1.1M on 2013-12-30.
Most recent recorded round closed around 2013-12-30.
Valuation (modeled)modeled
Provath models Avia Biosystems, Inc. at approximately $13M (range $1.0M–$106M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.64× the median modeled value of Seed Manufacturing companies in 2013–2015 (130 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 12.5 yr ago; this sector typically re-raises about every 12 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 38% of Manufacturing peers (3257 compared).
Modeled value ranks above 54% of those peers.
Closest niche peers: ABI Group LLC, Stable Imaging Solutions LLC, Genicon, Inc., Sfi Hold-Co Llc, Global Precision Products, LLC.
Peoplefiled
4 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.